文献速递冠心病心力衰竭与心肌病

慢性冠脉综合征患者缺血、大出血与心衰事件的发生率及预后影响比较:CORONOR注册研究

Comparison of Incidence and Prognostic Impact of Ischemic, Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
PubMed 文献 · Circulation · 2024-04-25

CORONOR为前瞻性多中心队列,纳入4184例连续非选择的慢性冠脉综合征门诊患者。中位随访4.9年,心衰住院是最常见且预后最差的事件之一,大出血虽较少见但与全因死亡强相关,二级预防不应仅限于预防缺血事件。

要点

  • 心衰住院5年累积发生率为8.1%,高于缺血事件的6.3%和大出血的3.1%。
  • 大出血后全因死亡率最高,达42.4%/年,心衰住院后为34.7%/年。
  • 二级预防应同时重视减少出血和预防心衰,而非仅预防缺血事件。

核心结论

  • 心衰住院已成为慢性冠脉综合征患者中最常见且预后最差的事件之一,大出血虽较少见但与更差生存强相关。
  • 二级预防不应仅限于预防缺血事件,减少出血和预防心衰可能至少同等重要。

研究设计与样本

  • CORONOR为前瞻性多中心队列研究,纳入4184例连续非选择的慢性冠脉综合征门诊患者。
  • 中位随访4.9年,分析缺血事件(心肌梗死与缺血性卒中的复合终点)、大出血(BARC 3级或以上)和心衰住院的发生率、相关因素及对后续死亡的影响。

主要发现

  • 随访期间677例患者(16.5%)死亡。
  • 5年累积发生率(以死亡为竞争事件)分别为:缺血事件6.3%(5.6%-7.1%)、大出血3.1%(2.5%-3.6%)、心衰住院8.1%(7.3%-9%)。
  • 事件后全因死亡率分别为:大出血42.4%/年、心衰住院34.7%/年、缺血事件13.1%/年。
  • 年龄和性别校正后的全因死亡风险比分别为:缺血事件3.57(95% CI,2.77-4.61)、大出血9.88(95% CI,7.55-12.93)、心衰住院8.60(95% CI,7.15-10.35),均P<0.001。

临床怎么用

  • 在慢性冠脉综合征门诊患者管理中,除缺血事件外,应同等关注出血风险和心衰预防。
  • 对发生大出血或心衰住院的患者,应识别为极高死亡风险人群并加强随访干预。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evaluation of the residual risk in patient with chronic coronary syndrome is challenging in daily practice. Several types of events (myocardial infarction, ischemic stroke, bleeding, and heart failure [HF]) may occur, and their impact on subsequent mortality is unclear in the era of modern evidence-based pharmacotherapy. METHODS: CORONOR (Suivi d'une cohorte de patients Coronariens stables en région Nord-pas-de-Calais) is a prospective multicenter cohort that enrolled 4184 consecutive unselected outpatients with chronic coronary syndrome. We analyzed the incidence, correlates, and impact of ischemic events (a composite of myocardial infarction and ischemic stroke), major bleeding (Bleeding Academic Research Consortium 3 or higher), and hospitalization for HF on subsequent patient mortality. RESULTS: During follow-up (median, 4.9 years), 677 patients (16.5%) died. The 5-year cumulative incidences (death as competing event) of ischemic events, major bleeding, and HF hospitalization were 6.3% (5.6%-7.1%), 3.1% (2.5%-3.6%), and 8.1% (7.3%-9%), respectively. Ischemic events, major bleeding, and HF hospitalization were each associated with all-cause mortality. Major bleeding and hospitalization for HF were associated with the highest mortality rates in the postevent period (42.4%/y and 34.7%/y, respectively) compared with incident ischemic events (13.1%/y). The age- and sex-adjusted hazard ratios for all-cause mortality were 3.57 (95% CI, 2.77-4.61), 9.88 (95% CI, 7.55-12.93), and 8.60 (95% CI, 7.15-10.35) for ischemic events, major bleeding, and hospitalization for HF, respectively (all P<0.001). CONCLUSIONS: Hospitalization for HF has become both the most frequent and one of the most ominous events among patients with chronic coronary syndrome. Although less frequent, major bleeding is strongly associated with worse patient survival. Secondary prevention should not be limited to preventing ischemic events. Minimizing bleeding and preventing HF may be at least as important.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Lemesle, Lamblin, Schurtz, et al. Comparison of Incidence and Prognostic Impact of Ischemic, Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry. Circulation. 2024. PMID: 38660793. doi:10.1161/CIRCULATIONAHA.123.067938

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。